Objective: To summarize key changes in the 2007 American College of Cardiology/American Heart Association (ACC/AHA) guideline recommendations for pharmacologic therapy as they relate to antiplatelets ...
PARSIPPANY, N.J. and INDIANAPOLIS, March 29, 2011 /PRNewswire/ -- Oral antiplatelet therapy Effient® (prasugrel) has been added to the updated clinical practice guidelines as a Class I recommended ...
DALLAS, TX and WASHINGTON, DC — The American Heart Association and the American College of Cardiology have issued a guideline for the management of patients with non-ST-elevation acute coronary ...
Guidance on the use of glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary syndromes
Coronary heart disease (CHD) is the most common cause of death in the UK. It is a progressive disease. The first presenting symptom is often stable angina (pain in the chest on exertion), which may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results